Condition

Glioblastoma

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 44 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials44
Recruiting13
Common interventions25
Lead sponsors shown15
Advertisement

Clinical trials

44 shown
The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced CancerNCT07636200 · 2026-05-04
RECRUITING
Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant TumorsNCT07552467 · 2026-04-01
RECRUITING
Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid TumorsNCT07410494 · 2026-02-01
RECRUITING
EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid TumorsNCT07410676 · 2026-02-01
RECRUITING
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding AreasNCT07285044 · 2025-12-18
RECRUITING
PET-imaging of Two Vartumabs in Patients With Solid TumorsNCT06645808 · 2024-12-10
RECRUITING
Investigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against CancerNCT07664579 · 2024-07-05
RECRUITING
MRI Guided Radiotherapy and Radiobiological Data: the ISRAR Database (Irm Sequences for Radiobiological Adaptative Radiotherapy)NCT06041555 · 2024-01-08
RECRUITING
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing TumorsNCT05283330 · 2022-12-22
RECRUITING
A Trial of RSC-1255 for Treatment of Patients With Advanced MalignanciesNCT04678648 · 2021-03-03
RECRUITING
Serial MRI Scans During Radiation TherapyNCT04188535 · 2020-01-15
RECRUITING
Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer PatientsNCT03787056 · 2018-12-04
RECRUITING
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryNCT03452774 · 2018-01-01
RECRUITING
ctDNA-Guided Intraventricular Therapy for CNS MalignanciesNCT07689721 · 2027-01-01
NOT_YET_RECRUITING
The Clinical Application Value of SPECT Imaging Targeting LRRC15 in Malignant TumorsNCT07651020 · 2025-03-01
COMPLETED
A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid TumorsNCT05538572 · 2022-12-27
COMPLETED
Correlation Between Prostate-specific Membrane Antigen Positron Emission Tomography and Arterial Spin Labeling Perfusion Imaging in GlioblastomaNCT06600399 · 2022-10-01
COMPLETED
A Study to Investigate 14C-bemcentinib in Healthy Male SubjectsNCT06469138 · 2022-08-02
COMPLETED
The BurnAlong Pilot Study for Adolescent and Young Adult Cancer SurvivorsNCT05131815 · 2022-07-25
COMPLETED
A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor CancerNCT04982926 · 2021-09-16
TERMINATED
Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor MalignanciesNCT04913337 · 2021-06-09
UNKNOWN
The Registry of Oncology Outcomes Associated With Testing and TreatmentNCT04028479 · 2021-05-05
COMPLETED
Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid TumorsNCT04541225 · 2020-12-08
TERMINATED
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer PatientsNCT04604158 · 2020-12-02
COMPLETED
A Phase 1-2 Study of ST101 in Patients With Advanced Solid TumorsNCT04478279 · 2020-07-01
ACTIVE_NOT_RECRUITING
Pediatric Long-Term Follow-up and Rollover StudyNCT03975829 · 2019-11-04
ACTIVE_NOT_RECRUITING
Neuro/Sacituzumab Govitecan/Breast Brain Metastasis/Glioblastoma/Ph 0NCT03995706 · 2019-07-17
COMPLETED
Memory Perception Assessment in Central/Non-central Nervous System CancersNCT03975959 · 2019-05-10
COMPLETED
Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)NCT03797326 · 2019-02-12
COMPLETED
A Phase 1 Study of ZSP1602 in Participants With Advanced Solid TumorsNCT03734913 · 2019-01-25
UNKNOWN
A Phase I Clinical Trial of Bevacizumab InjectionNCT05476341 · 2017-04-06
COMPLETED
Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant GlioblastomaNCT02968940 · 2017-03-17
COMPLETED
Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid TumorsNCT02709889 · 2016-09-23
TERMINATED
Improving Goals of Care Discussion in Advanced Cancer PatientsNCT02374255 · 2016-03-15
COMPLETED
89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma MultiformeNCT02410577 · 2015-04-01
COMPLETED
A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)NCT02327078 · 2014-11-26
COMPLETED
An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)NCT01598597 · 2012-03-01
COMPLETED
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsNCT01522820 · 2012-03-01
COMPLETED
HYPAZ: Hypertension Induced by PazopanibNCT01392352 · 2011-04-01
TERMINATED
Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2NCT01383135 · 2010-10-01
COMPLETED
Dendritic Cell Vaccination for Patients with Solid TumorsNCT01291420 · 2010-05-03
COMPLETED
The Effect of Monoclonal Vascular Endothelial Growth Factor (VEGF) Antibody (Bevacizumab) on Pituitary FunctionNCT00973557 · 2009-09-01
COMPLETED
Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered MalignanciesNCT04566393
AVAILABLE
Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer PatientsNCT05974410
AVAILABLE

Common interventions

²¹²Pb-DOTAM-GRPR1DRUG13 MRI sequences (T2*, IVIM and Multi Echo-Gradient), without injection, are performedOTHER189Zr-DFO-N-Suc-C9scFvBIOLOGICAL189Zr-DFO-N-Suc-F8scFvBIOLOGICAL189Zr-J591DRUG1autologous dendritic cell vaccinationBIOLOGICAL1AvelumabBIOLOGICAL1AVM0703DRUG1BemcentinibDRUG1Bevacizumab injectionDRUG1Bevacizumab injection（Avastin）DRUG1Biomarker Testing (L)DIAGNOSTIC_TEST1Blood drawOTHER1Blood drawsOTHER1Cancer Therapeutic ProcedureDRUG1ChemotherapyDRUG1Clinical Trial MatchingOTHER1CSF ctDNA-Guided Clinical ManagementDEVICE1dabrafenibDRUG1DEC-205/NY-ESO-1 Fusion Protein CDX-1401BIOLOGICAL1DexamethasoneDRUG1Dual-Target Antigen-Selected CAR-NKBIOLOGICAL1EB-SELECT Single-Target CAR-NK CellsBIOLOGICAL1EBNK-001 + IL-15 + PembrolizumabBIOLOGICAL1Elly Mobile Phone ApplicationBEHAVIORAL1

Trial status mix

COMPLETED20
RECRUITING13
TERMINATED4
ACTIVE_NOT_RECRUITING2
AVAILABLE2
UNKNOWN2
NOT_YET_RECRUITING1

Phase mix

PHASE116
PHASE211
NA9
EARLY_PHASE13
PHASE41
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.